1. Autosomal Dominant: 1 parent has, 50% change of child having
2. Autosomal Recessive: Both parents are carriers, 25% change of child having,
50% chance child is a carrier.
3. Cystic Fibrosis: affects pancreas causing secretions in lungs
4. 21st Trisomy: Down Syndrome
5. Klinefelter Syndrome (XXY): male has extra X, female like qualities
6. Turner Syndrome: Missing X in females
7. Alpha Thalassemia: inherited blood disorder; mild to severe anemia
8. Beta Thallasemia: low hemoglobin; contraindicated medication ferrous sulfate
9. Prevalence Risk: proportion of the population affected at a certain time
10. Incidence rate: number of new cases divided by population
11. Innate immunity: inflammation; increased vascular permeability
12. B&T lymphocytes: immune response
13. primary malignant tumor: lack of organization of cells
14. glucocorticoids: used in combination with other agent to treat lymphoid tissue
(leukemia). glucocorticoids are directly toxic to lymphoid tissues.
15. Selective estrogen receptor modulators (SERM): for hormone receptor pos-
itive and advanced breast cancer. (Tamoxifin reduces risk and recurrence risk)
16. Heart failure: impairment of the ventricle to fill with or eject blood; heart cannot
meet metabolic need of the body.
17. CHF: heart cannot keep up with metabolic needs; volume overload in pulmonary
area
18. Left Ventricular Dysfunction: reduced ejection fraction; ventricle having issue
ejecting blood.
19. normal ejection fraction: 55 - 60 % (blood pumped out with each heartbeat)
20. Ejection fraction of 50% - reduced or preserved?: preserved
21. Diastolic CHF: preserved ejection fraction, problem is with filling
22. Systolic CHF: reduced ejection fraction, problem is with ejecting
23. Left sided CHF: pulmonary (JVD, fluid volume overload, rails, S-3 murmurs) **
#1 cause of Right sided CHF
24. BNP: gold standard lab test to diagnose CHF
25. Echocardiogram: Diagnostic tool, evaluates heart structure and function
26. At Risk for HF - Stage A: no structural heart disease or symptoms of heart
failure
1/
10
, 27. Stage A HF co-morbidities: htn, atherosclerotic disease, diabetes, metabolic
syndrome, patients using cardiotoxins with family history
28. Therapy goals of stage A HF: treat htn, encourage smoking cessation, en-
courage regular exercise, treat lipid disorders, discourage alcohol intake/drug use,
control metabolic syndrome
2/
10
2. Autosomal Recessive: Both parents are carriers, 25% change of child having,
50% chance child is a carrier.
3. Cystic Fibrosis: affects pancreas causing secretions in lungs
4. 21st Trisomy: Down Syndrome
5. Klinefelter Syndrome (XXY): male has extra X, female like qualities
6. Turner Syndrome: Missing X in females
7. Alpha Thalassemia: inherited blood disorder; mild to severe anemia
8. Beta Thallasemia: low hemoglobin; contraindicated medication ferrous sulfate
9. Prevalence Risk: proportion of the population affected at a certain time
10. Incidence rate: number of new cases divided by population
11. Innate immunity: inflammation; increased vascular permeability
12. B&T lymphocytes: immune response
13. primary malignant tumor: lack of organization of cells
14. glucocorticoids: used in combination with other agent to treat lymphoid tissue
(leukemia). glucocorticoids are directly toxic to lymphoid tissues.
15. Selective estrogen receptor modulators (SERM): for hormone receptor pos-
itive and advanced breast cancer. (Tamoxifin reduces risk and recurrence risk)
16. Heart failure: impairment of the ventricle to fill with or eject blood; heart cannot
meet metabolic need of the body.
17. CHF: heart cannot keep up with metabolic needs; volume overload in pulmonary
area
18. Left Ventricular Dysfunction: reduced ejection fraction; ventricle having issue
ejecting blood.
19. normal ejection fraction: 55 - 60 % (blood pumped out with each heartbeat)
20. Ejection fraction of 50% - reduced or preserved?: preserved
21. Diastolic CHF: preserved ejection fraction, problem is with filling
22. Systolic CHF: reduced ejection fraction, problem is with ejecting
23. Left sided CHF: pulmonary (JVD, fluid volume overload, rails, S-3 murmurs) **
#1 cause of Right sided CHF
24. BNP: gold standard lab test to diagnose CHF
25. Echocardiogram: Diagnostic tool, evaluates heart structure and function
26. At Risk for HF - Stage A: no structural heart disease or symptoms of heart
failure
1/
10
, 27. Stage A HF co-morbidities: htn, atherosclerotic disease, diabetes, metabolic
syndrome, patients using cardiotoxins with family history
28. Therapy goals of stage A HF: treat htn, encourage smoking cessation, en-
courage regular exercise, treat lipid disorders, discourage alcohol intake/drug use,
control metabolic syndrome
2/
10
